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Sindbis virus virions incorporating uncleaved precursor envelope protein PE2 bind efficiently to cell-surface heparan sulfate (HS) because
the furin cleavage site (a consensus HS-binding domain) is retained in the mature virus particle. However, they are essentially nonviable.
Resuscitating mutations selected in the E3 or E2 protein preserve the PE2 noncleaving phenotype and HS binding, but facilitate fusion, and
thereby restore wild-type infectivity on cultured cells. Here, we have demonstrated that the resuscitated PE2 noncleaving virus was almost
avirulent in vivo, but mutated during the infection. Mutants had increased virulence and cleavage of PE2, with reduced HS binding capacity.
We hypothesize that HS binding leads to sequestration of PE2 noncleaving virus particles and suppression of serum viremia, thereby
selecting for evolution of the virus into a PE2-cleaving, low HS-binding phenotype.
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IntroductionSindbis virus is the prototypic virus of the Alphavirus
genus, family Togaviridae (reviewed by Johnston and
Peters, 1996). This group of arthropod-borne RNA viruses
includes several significant human pathogens and potential
bioterrorism/biowarfare agents (Burgess et al., 2001; Smith
et al., 1997). On the basis of the relative difficulty and risk
of handling the more pathogenic alphaviruses, Sindbis virus
has been studied extensively as a pathogenesis model. More
recently, Sindbis virus vector systems have also been
utilized in vaccine development (Gardner et al., 2000;
Huang, 1996; Polo et al., 1999; Pugachev et al., 1995)
and gene therapy (Tseng et al., 2002) applications. Conse-
quently, there has been a resurgence of interest in charac-
terizing Sindbis virus virulence/attenuation determinants.
Mature Sindbis virus particles contain an icosahedral
nucleocapsid composed of capsid (C) monomers, cloaked
in an envelope of membrane-anchored glycoprotein spike0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1994). The viral spike proteins facilitate attachment to cell
surfaces, fusion, and entry. The consensus wild-type Sindbis
virus strain, TR339, derived from an infectious clone that
resurrects the sequence of the original natural AR339 isolate
(Klimstra et al., 1998; McKnight et al., 1996; Klimstra et al.,
unpublished results), attaches initially to cells through a low
affinity, primarily heparan sulfate (HS)-independent mech-
anism (Klimstra et al., 1998). In contrast, laboratory strains
of Sindbis virus utilize cell-surface HS molecules as recep-
tors to varying degrees (Byrnes and Griffin, 1998; Klimstra
et al., 1998, 1999a). The HS-dependent cell-surface attach-
ment phenotype is conferred by the acquisition of positive-
charge amino acid mutations in the E2 attachment protein,
rapidly selected during passage in cultured cells (Klimstra et
al., 1998). Such mutations are believed either to form part of
a conformation-dependent, nonlinear, HS-binding sequence
or to promote the exposure of another such site (Klimstra et
al., 1998).
We have previously demonstrated a second, distinct
mechanism by which Sindbis virus can acquire the ability
to bind to cell-surface HS (Klimstra et al., 1999a). During
maturation of the virion, the precursor to the major E2
attachment protein, PE2, is cleaved by a host-encoded,
furin-like protease (Strauss and Strauss, 1994). Significant-
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hydrophobic) in the PE2 protein also represents an inverted,
consensus HS-binding domain (Cardin and Weintraub,
1989; Klimstra et al., 1999a). When the precursor PE2
protein is cleaved into the mature E2 glycoprotein, the E3
portion containing the BXBB site is lost from the virion, and
therefore this site would not be expected to contribute to the
virus–cell surface interaction. However, some laboratory
strains of Sindbis virus retain a minor uncleaved PE2
component in the spike protein structures on the surface
of the mature virion (Heidner and Johnston, 1994; Klimstra
et al., 1999a). In this case, the PE2 cleavage phenotype of
the virus is determined by the amino acid residue immedi-
ately downstream of the furin cleavage site, E2 position 1
(Heidner and Johnston, 1994; Heidner et al., 1994; Klimstra
et al., 1999a), and the proportion of PE2 incorporated into
the mature virion can be manipulated by mutating the amino
acid at this position (Table 1). TR339 almost completely
cleaves its PE2 glycoprotein (Klimstra et al., 1999a),
whereas in the envelope of virus derived from the infectious
clone of our laboratory Sindbis virus strain, designated
TRSB, f14% of the total E2 is in the PE2 form (Heidner
and Johnston, 1994; Klimstra et al., 1999a). A mutation
from Ser (TR339) to Arg (TRSB) at E2 position 1 is
responsible for this cleavage difference (Klimstra et al.,
1999a). The presence of PE2 has an enhancing effect on
cell-surface attachment that is correlated with the relative
PE2 content in the virus particles and dependent upon the
presence of the BXBB domain (Klimstra et al., 1999a).
Thus, the BXBB furin cleavage site in PE2 can mediate the
binding of PE2-containing Sindbis viruses to cell-surface
HS.
Previously,we generated aSindbis virusmutant (TRSB-N)
with an additional glycosylation site (Asn-Val-Thr) intro-
duced by substituting Asn at E2 position 1 (Heidner and
Johnston, 1994). Glycosylation at this site completely
abrogates furin-mediated PE2 cleavage. However, TRSB-
N virus particles, while attaching very efficiently to cell-Table 1
Summary of genotypes and phenotypes of viruses used in this studya
a Information taken from several sources including Heidner and Johnston (1994)
b Boldface type denotes amino acids mutated from the TRSB-E2S1 virus genom
binding site; underlining denotes potential glycosylation site, NXT.
c Percentage of PE2 as opposed to E2 incorporated into the envelope of the mat
d Indicates relative infectivity of radio-labeled virus particles on BHK cells givin
e Virulence following subcutaneous inoculation of neonatal mice measured in te
f Relative ability to bind HS determined by heparin-mediated inhibition of plaque
or cells treated with heparinase.surface HS through the BXBB site, are nonviable (Heidner
and Johnston, 1994; Heidner et al., 1994) presumably
because of inhibition of fusion or other uncoating processes
(Smit et al., 2001). Second-site mutations in either E3 or E2
(e.g., E2 Gly 216) were selected, which maintain the PE2
noncleaving phenotype, but restore virus infectivity in vitro
(Heidner et al., 1994). These mutations are referred to as
‘‘resuscitating’’ mutations. The E2 Gly 216 mutation does
not alter the efficiency of virion binding to cells (Heidner et
al., 1994), but improves the efficiency of uncoating and
entry (Smit et al., 2001), resulting in an overall increase in
infection efficiency in vitro.
We have previously observed that the consensus wild-
type TR339 virus is significantly more virulent in neonatal
mice than cell culture-adapted, HS-binding Sindbis virus
strains with positive-charge mutations in E2 or partial PE2
incorporation (Klimstra et al., 1998, 1999a). This suggests
that increased HS-binding and cell culture adaptation are
inversely correlated with virulence in vivo. Similarly, while
the resuscitated PE2 noncleaving mutants exhibit normal or
nearly normal growth in BHK-21 (Heidner et al., 1994),
Neuro-2A and primary mouse embryo fibroblast cells
(Ryman and Johnston, unpublished data) are attenuated in
mice (Heidner et al., 1994). Here, we have investigated the
mechanism of attenuation of in vivo replication in the PE2
noncleaving viruses by analyzing virulent mutants selected
during their replication within the host.Results
Construction and characterization of viruses
The genotypes and phenotypes of the viruses used in this
study are summarized in Table 1. pTR339 is a full-length
cDNA clone constructed to encode the consensus wild-type
Sindbis AR339 virus sequence (Klimstra et al., 1998;
McKnight et al., 1996; Klimstra et al., unpublished results)., Heidner et al. (1994), Klimstra et al. (1998, 1999a), and the current study.
e sequence; shading denotes BXBB PE2 furin cleavage site/consensus HS
ure virion.
g relative particle/PFU ratio.
rms of morbidity, mortality, and AST.
formation, binding to and infectivity for HS- and GAG-deficient CHO cells
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Sindbis virus AR339 (McKnight et al., 1996). The wild-type
phenotype is conferred by the exchange of Ser at E2
position 1 of pTR339 for Arg in pTRSB. pTR339 also
differs from pTRSB at two other codons; nsp3 528 and E1
72 (Klimstra et al., 1998, 1999b). The virus clone with E2
Ser 1 in the TRSB background is designated pTRSB-E2S1.
In this study, virus derived from clones with an E2 Asn 1 in
the pTRSB background (pTRSB-N and pTRSB-NE2G216)
is compared with pTRSB, pTRSB-E2S1, and pTR339-
derived viruses. The substitution of Asn at E2 1 creates an
Asn-Val-Thr glycosylation site, which prevents furin-medi-
ated cleavage of the PE2 precursor protein into E2, such that
the TRSB-N virus is essentially nonviable. TRSB-
NE2G216 is a revertant of TRSB-N in which a second-site
viability-resuscitating Glu to Gly mutation has been selected
at E2 216. pTRSB-E2G216 contains only the E2 Gly 216
resuscitating mutation from pTRSB-NE2G216 cloned inde-
pendently into the pTRSB sequence background.
Virulence of PE2 noncleaving Sindbis virus in neonatal
mice
Previous studies have demonstrated that although the
resuscitated PE2 noncleaving viruses are not significantly
restricted for growth in mammalian cells in vitro compared
with TRSB, they are attenuated in vivo in terms of
mortality rate and average survival time (AST; Heidner
et al., 1994). To extend these observations, groups of
neonatal mice, 12–24 h post-partum (p.p.), were inoculat-
ed subcutaneously with 103 PFU of Sindbis virus strains
TRSB, TRSB-E2S1, TR339, TRSB-E2G216, and TRSB-
NE2G216, or mock-infected with PBS-1% donor calf
serum (DCS). The percent survival of the virus-infected
mice over the course of the experiment was determined
(Fig. 1A). Confirming previous findings, TRSB, TRSB-
E2S1, and TR339 viruses caused 100% mortality in
neonatal mice with ASTs of 4.25 F 0.88, 2.08 F 0.49,
and 2.16 F 0.26 days, respectively. In comparison, TRSB-
NE2G216, the resuscitated PE2 noncleaving virus, was
significantly attenuated, with a mortality rate of 73% and
an AST of 9.55 F 3.33 days. Similar results were obtained
in two repeats of this experiment. Interestingly, the sur-
vival times of individual neonatal mice infected with
TRSB-NE2G216 were widely divergent, with deaths
occurring between 3 and 18 days postinfection (p.i.). Daily
weight change in TRSB-NE2G216-infected mice was used
as a determinant of the clinical severity of infection (Fig.
1B). By individually identifying the TRSB-NE2G216-
infected mice, it was possible to determine the severity
of infection in each mouse and to predict the outcome of
the infection several days before death. Overt clinical signs
of disease varied from ataxia with rapid mortality through
paresis with extended AST to a nonfatal flaccid hind-limb
paralysis. TRSB-E2G216 virus, containing only the resus-
citating mutation in the TRSB sequence background, wasnot significantly attenuated compared with the parental
viruses.
Virus replication and dissemination in neonatal mice
The pathogenesis of Sindbis virus infection in mice has
been extensively studied. When inoculated subcutaneously
into neonatal mice, consensus wild-type TR339 virus rep-
licates in extraneural tissues, seeding a high titer serum
viremia. Viremia facilitates neuroinvasion and replication
occurs in the CNS tissues immediately before death (Klim-
stra et al., 1999b). Cell culture-adapted, HS-binding Sindbis
virus strains were more attenuated, with restricted replica-
tion (Klimstra et al., 1999b; Trgovcich et al., 1996). To
obtain correlates for virulence of TRSB, TRSB-E2G216 and
TRSB-NE2G216, serum and brain tissue were collected
from virus-infected neonates at 24 h intervals p.i., and
infectious virus particles were titered (Figs. 2A, B). Repli-
cation of TRSB and TRSB-E2G216 varied little between
infected animals reaching titers of 107–108 PFU/ml in
serum and 108–109 PFU/g in brain before the death of the
mouse, suggesting that infection severity does not differ
significantly from one infected animal to another. In con-
trast, virus titers in serum and brain harvested from different
TRSB-NE2G216-infected mice showed significant dispar-
ities on each day p.i. Virus titers correlated closely with the
percent weight gain/loss and predicted severity of the
infection (data not shown). Unlike TRSB-NE2G216 virus
stocks, which exhibit a uniformly small-plaque phenotype
compared with TRSB, the plaque size of virus titered from
the infected mice was frequently mixed. These data are in
keeping with the differences described in mortality rate,
AST, and clinical signs of infection.
Pathological correlates of infection severity
We have previously described interferon alpha/beta (IFN-
a/h) induction and thymic involution as reliable indicators
of a severe Sindbis virus infection. IFN-a/h induction
parallels virus replication and severity of infection (Klimstra
et al., 1999b; Trgovcich et al., 1996; Vilcek, 1964). Thymic
involution is not associated with virus replication, but
instead correlates with proinflammatory cytokine induction
(Klimstra et al., 1999b; Trgovcich et al., 1997). Measure-
ment of virus titer offers only a ‘‘snapshot’’ view of a
process ongoing within the infected mouse and therefore
IFN-a/h induction, and the severity of virus-mediated or
cytokine-mediated lesions were used as more enduring
correlates of virulence. Induced levels of IFN-a/h in both
serum and brain were proportional to virus titer (Figs. 2C,
D). The severity of both cytokine-mediated and virus-
mediated lesions in TRSB-NE2G216-infected mice corre-
lated with weight loss and clinical signs (data not shown).
The correlation of all these criteria strongly suggested that
the severity of disease caused by the same input virus in
different animals was widely divergent.
Fig. 1. Attenuation of virulence of PE2-containing TRSB-NE2G216 virus in neonatal mice. Neonatal mice, 12–24 h p.p., were infected subcutaneously in the
ventral thorax with 103 PFU of virus or mock-infected with virus diluent to generate a mortality curve for each virus (panel A): mock-infected (open circles),
TRSB (closed triangles), TRSB-E2S1 (closed squares), TRSB-E2G216 (open triangles), TR339 (open squares), and TRSB-NE2G216 (closed circles). TRSB-
NE2G216-infected mice were weighed daily and percent weight change relative to starting weight (1 day p.p.) was used as an indicator for severity of disease
(panel B): TRSB-NE2G216-infected (closed circles) and mock-infected (open circles).
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The differences observed in the severity of clinical signs
caused by infection with the TRSB-NE2G216 virus lead to
the speculation that the virus was evolving into a more
virulent form(s) within the mouse. Virus clones were
isolated by plaque purification from serum or brain tissues
of TRSB-NE2G216-infected mice 2, 3, 4, 5, 6, 8, or 10
days p.i., and amplified once on BHK-21 cells. The
amplified plaque-purified variants were inoculated subcu-
taneously into neonatal mice at a dose of 103 PFU. A
range of virulence phenotypes were observed (Fig. 3 andTable 2), which could be divided into two groups: (1)
attenuated viruses causing less than 100% mortality with
ASTs of 6–9 days, and (2) virulent viruses causing 100%
mortality with ASTs of <2–4 days. In most cases, the
virulence of the plaque isolates correlated with the severity
of the infection in the mouse from which the virus was
selected (see below).
Genotyping of plaque isolates
Viral RNA was extracted from plaque-isolated, ampli-
fied virus particles and amplified by RT-PCR for se-
Fig. 2. Virus titers and corresponding IFN-a/h levels in serum and brain of virus-infected neonatal mice. Neonatal mice were inoculated subcutaneously with
103 PFU virus and sacrificed at various times p.i. Virus titers in serum (panel A) and brain (panel B) were determined by BHK plaque assay. Levels of
biologically active IFN-a/h in serum (panel C) and brain (panel D) were measured for the same mice. Results are plotted for individual mice infected with
TRSB (solid black bars), TRSB-E2G216 (hatched bars), or TRSB-NE2G216 (solid white bars). The lower limit of detection is indicated (broken line).
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cleavage sites at the E3/E2 junction in PE2. Five virus
genotypes were present among virus clones isolated 3, 6,Fig. 3. Average survival times of neonatal mice infected with virus plaque isol
subcutaneously with 103 PFU of virus, plaque isolated from serum (panel A), or br
standard error of the mean (SEM). The source of the plaque isolate is indicated by
A serum and is the first of two such isolates; sample ‘‘2AB-1’’ was isolated 2 daor 8 days p.i. (Table 2). Virus clones with the original
genotype (E2 Asn 1/Thr 3) were isolated from samples
with titers in the range of 62.5–1.2  104 PFU/ml or g.ated from TRSB-NE2G216-infected mice. Neonatal mice were inoculated
ain (panel B) of TRSB-NE2G216-infected mice. ASTs are shown in days F
the sample name: e.g., sample ‘‘3AS-1’’ was isolated 3 days p.i. from mouse
ys p.i. from mouse A brain and is the first of two such samples.
Table 2
Source, genotype and phenotype of in vivo-selected mutant viruses
a Denotes the source of each plaque isolate as described in Fig. 3.
b Titer of virus in the sample from which the mutant was isolated.
c Mortality rate and AST following subcutaneous inoculation of neonatal mice with 103 PFU amplified plaque isolate.
d BHK-specific infectivity normalized to 1.0 for TRSB-NE2G216 (E2 Asn 1/Thr 3).
e Relative extent of uncleaved PE2 incorporation calculated by the formula PE2/(PE2 + E2 + E1 + C) such that a noncleaving virus with 100% PE2
incorporation has a value of z0.259 (7 methionine residues in PE2 of 27 total methionine residues).
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ously, E2 Ser 1/Thr 3 (TRSB-E2S1) and E2 Arg 1/Thr 3
(TRSB), were isolated from samples titered at 7.5  105–
5.5  106 and 700 PFU/ml or g, respectively. In addition,
two new virus genotypes, E2 Asn 1/Ala 3 and E2 Asn 1/
Ile 3, were isolated from samples titered at 1.5  105 and
2.2  103–7.2  106 PFU/ml or g, respectively. Neonatal
mouse virulence co-segregated with genotype such that
the order of virulence was E2 Ser 1/Thr 3 > E2 Asn 1/Ile
3 > E2 Asn 1/Ala 3 > E2 Arg 1/Thr 3 > E2 Asn 1/Thr 3.
Every paired sample (two plaque isolates from the same
sample) was identical except one. From mouse 3B (3
days p.i.), three clones of E2 Asn 1/Thr 3 (TRSB-
NE2G216) and one clone of E2 Asn 1/Ile 3 were isolated.
The presence of more than one virus genotype (and
anticipated corresponding PE2 cleavage phenotype) in
the same sample or the same mouse suggested that the
selection process was ongoing. However, once a virulent
virus clone was selected, it rapidly became the predom-
inant genotype. Virus clones isolated from the CNS of
mice 8 days p.i. were all of a more virulent genotype, E2
Ser 1/Thr 3, E2 Asn 1/Ala 3, or E2 Asn 1/Ile 3. Because
the severity of infection and predicted outcome amongst
these mice ranged from fatal to nonfatal, these data
suggested that selection of a more virulent virus genotype
may always occur eventually, but that the time of rever-sion may be critical in determining the outcome of the
infection.
PE2 cleavage phenotypes and specific infectivities of plaque
isolates
The PE2 cleavage phenotypes and specific infectivities
(i.e., the ratio of incorporated cpm to PFU) of the
five virus genotypes isolated from TRSB-NE2G216-
infected mice were compared (Table 2). A completely
noncleaving virus (100% PE2) should give a ratio of
PE2/(PE2 + E2 + E1 + C) of 0.259 (7 methionine re-
sidues in PE2 of 27 total methionine residues). Although
the E2 Asn 1/Thr 3 virus had a PE2 noncleaving phe-
notype as expected (>0.259), the remaining three geno-
types exhibited partial to complete PE2 cleavage in the
order E2 Arg 1/Thr 3 (0.053 F 0.000) < E2 Asn 1/Ala 3
(0.052 F 0.004), E2 Asn 1/Ile 3 (0.024 F 0.011) < E2
Ser 1/Thr 3 (0.023 F 0.007). The specific infectivity of
these viruses on BHK cells was directly proportional to
the PE2 content.
HS-binding phenotypes
We have previously demonstrated that viruses incorpo-
rating a proportion of PE2 bind to the cell surface via HS-
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resuscitating mutation on HS-dependent infection, virus
infectivity was evaluated on wild-type CHO K1 cells and
CHO mutants defective in GAG synthesis (pgsA-745) (Esko
et al., 1985; Klimstra et al., 1998). On the basis of variable
cytopathic effect on these CHO-derived cell lines, double-
promoter viruses expressing green fluorescent protein (GFP)
were used in a fluorescent center assay to evaluate infectiv-
ity (Fig. 4). Although the PE2 noncleaving virus, TRSB-N,
is known to bind efficiently to wild-type CHO K1 cells via
an HS-dependent mechanism, as expected, the virus had
extremely limited infectivity. The resuscitating E2 Gly 216
mutation in TRSB-NE2G216 restored infectivity for CHO
K1 cells, although HS-dependent cell-surface attachment
remained unaffected (data not shown). The resuscitating
mutation alone in the TRSB background (TRSB-E2G216)
did not confer an attachment/infectivity advantage over
TRSB.
The HS-dependence of the plaque-isolated revertants
selected in vivo was assessed in infectivity assays. GFP-
expressing double promoter viruses encoding E2 Ser 1/Thr
3 (E2S1-3VGFP), E2 Arg 1/Thr 3 (TRSB-3VGFP), and E2
Arg 1/Thr 3 with E2 Gly 216 (TRSB-E2G216-3VGFP)
were already available. An RT-PCR amplified fragment
was cloned into the E2S1-3VGFP double-promoter virus
between the StuI and BssHII restriction sites, thereby
replacing the E3/E2 protein junction of PE2 and introduc-
ing the E2 Ser 1, E2 Ala 3, E2 Ile 3 mutations identified inFig. 4. HS-binding phenotypes of TRSB-NE2G216 and plaque-isolated viruses. Th
GFP-expressing double-promoter viruses for wild-type CHO-K1 cells and CHO c
each cell type were infected with 100–200 PFU followed by three washes wit
expressing GFP were enumerated by fluorescence microscopy. The relative infe
infected/the average number of CHO K1 cells infected)  100%. Data represent thethe plaque-isolated revertants in combination with E2 Gly
216. The relative numbers of GFP-positive infected cells
on CHO K1 and GAG-deficient pgsA-745 cells were
analyzed (Fig. 4). Decreased efficiency of HS-binding
correlated with increased virulence and with increased
extent of PE2 cleavage.Discussion
In this study, we have characterized the pathogenesis of
the resuscitated PE2 noncleaving TRSB-NE2G216 Sindbis
virus variant, to further investigate the effects of HS-
mediated attachment on virulence in vivo. Enhanced in-
fectivity mediated by binding of the BXBB furin cleavage
site to cell-surface HS appears to be a delicate balance
between increased attachment efficiency and decreased
fusion competence. Thus, partial PE2 noncleaving viruses
such as TRSB are more infectious in vitro than consensus
wild-type TR339 virus (which almost completely cleaves
PE2), although the PE2 noncleaving virus, TRSB-N, is
nonviable. In vitro, we believe that the attenuating factor is
the inability of the virus to fuse with host cell membranes
after binding to the cell surface (Smit et al., 2001). The
resuscitating mutation at E2 position 216 and other resus-
citating mutations identified by Heidner et al. (1994)
restore the ability of the PE2 noncleaving virus to replicate
in mammalian cells. TRSB-NE2G216 virus binds efficient-e infectivities of TRSB-E2S1, TRSB, TRSB-E2G216, and TRSB-NE2G216
ell mutants deficient in GAGs (pgsD-745) were compared. Monolayers of
h PBS-1% DCS, medium replacement, and incubation for 8–12 h. Cells
ctivity was calculated as follows: (the average number of pgsD-745 cells
average of three infections and were reproduced in two independent assays.
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fore, the BHK cell-specific infectivity of TRSB-NE2G216
is greater than that of TR339 and similar to that of TRSB.
However, in vivo, the resuscitated TRSB-NE2G216 virus
remains significantly attenuated compared with either
TR339 or TRSB viruses.
Pathogenesis of resuscitated PE2 noncleaving virus
In neonatal mice, Sindbis virus strains cause a range of
disease phenotypes. Replication of a given virus strain may
be quantitatively, but not qualitatively, distinct, leading to a
very different innate immune response that apparently
determines the outcome of the infection. At one end of
the spectrum, consensus wild-type TR339 virus is highly
virulent in neonatal mice when administered by subcutane-
ous inoculation (Klimstra et al., 1999b). Increased mortality
and decreased AST were correlated with higher levels of
virus replication and increased magnitude of induction of
proinflammatory cytokines and systemic stress response
mediators, reminiscent of a systemic inflammatory response
syndrome (SIRS). This is observed in the absence of
classical encephalitis. Severe thymic involution is consistent
with the high levels of tumor necrosis factor alpha (TNF-a)
or corticosterone. Increasing divergence from the consensus
sequence with adaptation to growth in cultured cells occurs
coincident with attenuation of virulence, diminished SIRS-
like disease signs, and appearance of encephalitic pathology
(Klimstra et al., 1999b).
Overall, the disease caused by TRSB-NE2G216 virus in
neonates is significantly attenuated compared to TR339 and
TRSB viruses, with 50–75% mortality and an extended
AST. However, the range of disease severities exhibited by
TRSB-NE2G216-infected mice is very diverse. We have
compared and correlated several virulence factors to predict
the outcome of a given infection. Clinical signs, titers, and
pathological correlates all suggest that infection with the
PE2 noncleaving virus, TRSB-NE2G216, is not consistent.
Severity appears to range from rapidly fatal with extensive
virus replication, cytokine induction and thymic involution
(similar to TR339), to attenuated with restricted virus
replication, little or no cytokine-mediated pathology and
mild encephalitic sequelae.
Reversion to virulence in vivo
The above observations strongly suggested that a dy-
namic process of virus adaptation to the host was occurring
during the infection. By isolating individual virus clones
from the TRSB-NE2G216-infected mice, we were able to
analyze this selection process at the molecular level. In
addition to the original virus genotype, four predominant
mutations were selected. Two of these were characterized
previously, E2 Ser 1/Thr 3 (TRSB-E2S1) and E2 Arg 1/Thr
3 (TRSB), and two were unique, E2 Asn 1/Ala 3 and E2
Asn 1/Ile 3. Determination of the PE2 cleavage phenotypeof the revertant viruses revealed that the reverting mutations
increased cleavage of the PE2 precursor protein at the E3/
E2 junction by ablating the Asn-Val-Thr glycosylation site
at E2 position 1. This was achieved by mutating either the
Asn at E2 position 1 to Arg or Ser, or the Thr at E2 position
3 to Ile or Ala while retaining the E2 Asn 1. The
resuscitating mutation at E2 position 216 was retained in
each revertant. This was not surprising as this mutation did
not attenuate the virus and only appears to have a pheno-
type in combination with the E2 Asn 1 mutation. The
reverting mutations selected also enhanced the virulence of
each virus in vivo. All of the revertant viruses caused 100%
mortality in neonatal mice with slightly different ASTs such
that the order of virulence was E2 Ser 1/Thr 3 > E2 Asn 1/
Ile 3 > E2 Asn 1/Ala 3 > E2 Arg 1/Thr 3 > E2 Asn 1/Thr 3.
More than one mutation was not selected in the same
animal, suggesting that once selected, the PE2 cleaving
virus replicates and disseminates rapidly becoming the
predominant genotype. The rapidity with which this selec-
tion occurs in vivo likely determines the outcome of
infection.
Reversion to non-HS-binding phenotype in vivo
Although an expanding group of viruses is being shown
to bind to cell-surface HS in vitro, only a limited number of
studies have examined the influence of HS-mediated attach-
ment on infection in vivo including studies of HSV
(WuDunn and Spear, 1989), FMDV (Sa-Carvalho et al.,
1997), VEEV (Bernard et al., 2000), Sindbis (Byrnes and
Griffin, 2000; Klimstra et al., 1998), and classical swine
fever virus (Hulst et al., 2001). We have demonstrated that
Sindbis virus acquires the ability to bind HS as an adapta-
tion to growth in cultured cells (Klimstra et al., 1998). We
(Bernard et al., 2000; Klimstra et al., 1998, 1999a) and
others (Byrnes and Griffin, 1998, 2000) have proposed that
the ability of alphaviruses to bind HS results in attenuation
in vivo because of a decreased ability to spread from the site
of inoculation and seed a sustained serum viremia. Heparin-
binding proteins are rapidly sequestered by tissue HS,
particularly by the highly sulfated HS found in the liver
(Bernfield et al., 1992; Lyon et al., 1994). By comparison,
wild-type non-HS-binding viruses would be expected to
seed a higher titer viremia, clear more slowly from the
blood, and likely cause higher mortality (Bernard et al.,
2000; Byrnes and Griffin, 2000; Klimstra et al., 1998).
Similar conclusions have been made for other viruses
including FMDV (Sa-Carvalho et al., 1997) and classical
swine fever virus (Hulst et al., 2001). Byrnes and Griffin
(2000) have directly linked the rapid clearance of certain
attenuated Sindbis virus strains from the bloodstream with
the HS-binding phenotype and demonstrated that there are
strong selection pressures in vivo against cell culture-adap-
tive, positive-charge amino acid mutations, and for the
ability to disseminate efficiently throughout the host in the
circulatory system.
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the resuscitated PE2 noncleaving viruses are not significant-
ly restricted in their ability to infect and propagate within
mammalian cells in vitro (Heidner et al., 1994), although
their replication remains defective in arthropod cells because
of a block in egress (Boehme et al., 2000; Heidner et al.,
1996). However, although TRSB-NE2G216 virus binds
better to and is more infectious for mammalian cells than
the consensus wild-type TR339 virus, the virus spontane-
ously reverted to a PE2-cleaving, low/non-HS-binding phe-
notype during infection of neonatal mice by ablation of the
glycosylation site at E2 position 1. We believe this is, at
least in part, due to a strong positive selection pressure for
the ability to spread in vivo. The reversion event appeared to
be relatively inefficient and occurred at different times p.i.
resulting in less than 100% mortality and divergent survival
times. These data further suggest that while the presence of
PE2 is necessary to protect the virus from premature fusion
with the infected host cell endoplasmic reticulum during
egress (Carleton et al., 1997), the PE2 precursor protein
must be cleaved during maturation to facilitate dissemina-
tion of the virus within the host. The virus is able to mutate
rapidly in the infected animal to maximize its ability to
replicate, seed a high titer serum viremia, and disseminate
throughout the host. This capability is of critical importance
in the lifecycle of any arthropod-borne virus in nature, to
facilitate transmission via a blood meal to the mosquito
vector.
While these data provide a strong correlation between
incorporation of PE2 in the virion, the ability to bind to HS
and attenuation of the virus in vivo, viruses with Asn at E2
position 1 also differ from PE2-cleaving viruses by the
retention of E3 in the virion and by the possession of an
extra glycosylation site. Mutations to Leu or Val at E2
position 1 have also been shown to block PE2 cleavage and
attenuate virulence of Sindbis virus (Heidner and Johnston,
1994; Klimstra et al., 1999a), suggesting that addition of a
glycosylation site is not solely responsible for reduced
virulence. We have recently demonstrated, however, that
carbohydrate modifications on the virion surface in mos-
quito-derived Sindbis virus mediate attachment to cell-
surface C-type lectin molecules, dendritic cell (DC-SIGN),
and liver/lymph node (L-SIGN)-specific ICAM-3 grabbing
non-integrins (Klimstra et al., 2003). It is also conceivable
that the retention of E3 in the mature particle may contrib-
ute to the attenuated phenotype by as yet unidentified
mechanisms.
Relevance to other virus families
In the last 5 years, HS binding has been implicated in the
in vitro infection of cells by laboratory strains of a large
number of viruses. However, with the exception of herpes-
viruses (WuDunn and Spear, 1989), a role for HS interaction
has not been established with natural virus isolates. For
several of these viruses, including Sindbis virus (Klimstra etal., 1998), VEEV (Bernard et al., 2000), Murray Valley
encephalitis virus (Lee and Lobigs, 2000, 2002), FMDV
(Jackson et al., 1996; Sa-Carvalho et al., 1997), and classi-
cal swine fever virus (Hulst et al., 2000, 2001), the ability to
bind cell-surface HS has been linked with cell culture
adaptation and attenuation in vivo.
The surface glycoproteins of many enveloped viruses,
including retroviruses (Hallenberger et al., 1992), paramyx-
oviruses (Bolt and Pedersen, 1998; Bolt et al., 2000; Fujii et
al., 1999), Borna disease virus (Gonzalez-Dunia et al.,
1998), filoviruses (Feldmann et al., 1999), orthomyoviruses
(Jankovics, 1996), and flaviviruses (Chambers et al., 1990),
are initially synthesized as inactive precursors, and proteo-
lytic cleavage is often required for maturation and fully
functional activity. In several virus families, this processing
step is carried out by cellular proprotein convertases, most
commonly furin, a component of the constitutive secretory
pathway of many different types of cells. Therefore, many
of these viruses possess potential HS-binding domains.
Therefore, this study has wide applicability, particularly
amongst viruses that are dependent upon a serum viremia
for dissemination.Materials and methods
Cell culture
Baby hamster kidney cells (BHK-21: ATCC CCL-10)
were maintained in alpha minimal essential medium
(aMEM), supplemented with 10% donor calf serum
(DCS), 2.9 mg/ml tryptose phosphate, 0.29 mg/ml L-gluta-
mine, 100 U/ml penicillin, and 0.05 mg/ml streptomycin
(37 jC; 5% CO2). Chinese hamster ovary (CHO K1; ATCC
CRL-61) and CHO mutant (psgA-745; ATCC CRL-2242)
cells were maintained in Ham’s F-12 medium supplemented
with 10% fetal bovine serum.
Viruses
Virus stocks were generated from cDNA clones. Con-
struction of the pTR339, pTRSB, pTRSB-E2S1, pTRSB-N,
pTRSB-E2G216, pTRSB-NE2G216 plasmids has been de-
scribed previously (Heidner and Johnston, 1994; Heidner et
al., 1994; Klimstra et al., 1998; McKnight et al., 1996).
Viruses expressing GFP from a second 26S subgenomic
promoter were constructed by introducing the mut2-gfp
gene (kindly provided by Dr. Stanley Falkow, Stanford
University) into the Sindbis virus double 26S promoter
vector, pTE3V2J, a generous gift from Dr. Charles Rice
(Rockefeller University). The BsiWI–XhoI fragment of
pTE3V2J-GFP was cloned into pTRSB. This construct con-
tains a second copy of the 26S subgenomic promoter driving
expression of the gfp gene downstream of the authentic 26S
promoter, but is otherwise isogenic with pTRSB (pTRSB-
3VGFP). By exchanging a StuI–BssHII restriction fragment
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viruses coated in the E2 protein variants were generated.
All genetic manipulations were confirmed by DNA se-
quencing at the UNC-CH Automated DNA Sequencing
Facility using a model 373A DNA sequencer and the Taq
DyeDeoxy terminator cycle sequencing kit (Applied Bio-
systems). Infectious viral RNA was transcribed in vitro
from XhoI-linearized plasmid DNA template and trans-
fected into BHK-21 cells by electroporation. Virus par-
ticles were harvested from the supernatant after 18–20 h,
clarified by centrifugation, and stored at 70 jC in single-
use aliquots. Virus stocks were titered by standard BHK-21
cell plaque assay and titers were expressed as PFU/ml. For
mouse inoculations, a thawed virus stock aliquot was
diluted in low-endotoxin, phosphate-buffered saline sup-
plemented with 1% DCS (PBS-1% DCS). Single-use
aliquots of diluted virus were stored at 70 jC and the
titer of one thawed aliquot was confirmed by BHK plaque
assay.
Mouse procedures
Timed pregnant CD-1 mice (13–15 days gestation) were
obtained (Charles River). Mouse pups born within a 12-
h period were pooled and randomized as 10–12 pup litters.
Virus inocula containing 103 PFU virus in 50 Al (2  104
PFU/ml) were administered subcutaneously in the ventral
thorax using a 27-gauge needle and 1-ml hypodermic
syringe. Mock-infected mice received 50 Al of PBS-1%
DCS by the same route. Virus-infected and corresponding
mock-infected mice were observed at 12-h intervals, scored
for degree of sickness, and weighed at 24-h intervals where
appropriate. Individual mouse pups were identified by India
ink ‘‘tattooing’’ of the hindquarters. AST and percent
mortality were calculated.
Pathogenesis studies
At predetermined intervals, p.i. groups of three mice per
treatment were randomly selected from different litters. The
thoracic cavity of each mouse was opened under Metofane-
anesthesia (Schering-Plough) and blood was collected by
cardiac puncture. Serum was separated from whole blood
using microtainer tubes (Becton-Dickinson), aliquoted, and
stored at 70 jC. Each mouse was perfused with PBS-1%
DCS for 10 min at a rate of 1.5 ml/min. Brain tissues were
homogenized in PBS-1% DCS (33% suspension) by one
freeze-thaw and mechanical disruption, and clarified by
centrifugation (13000  g, 15 min, 4 jC). The supernatant
was assayed for virus by standard plaque assay or for IFN-
a/h as described below.
IFN-a/b assay
Serum IFN-a/h was titered by standard biological
assay on L929 cells as described previously (Trgovcichet al., 1996), using a commercially prepared IFN-a/h
standard (Access Biomolecular) and encephalomyocardi-
tis virus (EMCV) as the indicator virus. The endpoint
was defined as the dilution of IFN-a/h required to
protect 50% of the cells from EMCV-induced cpe and
the level of IFN-a/h was expressed as international units
(IU)/ml or g.
Histopathology
Three mice per treatment were randomly selected from
different litters. Under anesthesia, each mouse was per-
fused with 4% paraformaldehyde (PFA) in PBS (pH 7.4)
as described above. Whole PFA-perfused mice were
further fixed in 4% PFA (pH 7.4) for 1 week when
tissues were paraffin-embedded and sectioned. Hematoxy-
lin and eosin (H&E) stained sections were viewed by light
microscopy.
Revertant viruses
Individual virus plaques formed on BHK cells were
isolated using sterile plastic 1-ml Pasteur pipettes and
resuspended in supplemented aMEM. The virus from
each plaque was amplified by one round of replication
in BHK cells infected at high moi. Viral RNA was
extracted from virus particles in the supernatant using
Ultraspec reagent (Biotecx), and the E2 gene was ampli-
fied by RT-PCR. PCR products were sequenced as de-
scribed above. PCR fragments were digested with StuI and
BssHII and cloned directly into the GFP-expressing dou-
ble-promoter virus infectious clone template to generate
mutant virus.
Fluorescent center assay
Fluorescent center assays were performed essentially as
described by Klimstra et al. (1998). CHO K1 and CHO
mutant (pgsA-745) cells seeded in 24-well plates were
infected for 1 h at 37 jC with GFP-expressing double-
promoter viruses serially diluted in 200 Al PBS-1% DCS.
Monolayers were washed twice with PBS-1% DCS and
overlaid with 1% immunodiffusion agarose (ICN)-contain-
ing growth medium. Approximately 24 h p.i., plaques of
virus-infected cells expressing GFP were enumerated under
a Nikon fluorescence microscope using a fluorescein iso-
thiocyanate filter block.
Specific infectivity assays
Radiolabeled virus was prepared by incubation of virus-
infected BHK cell monolayers with 10 ACi/ml [35S]-methi-
onine (Amersham), purified on a discontinuous sucrose
gradient and concentrated by pelleting through sucrose
(Heidner and Johnston, 1994; Klimstra et al., 1998). The
BHK cell-specific infectivity (PFU per count per minute
K.D. Ryman et al. / Virology 322 (2004) 1–12 11[cpm]) was calculated for each virus preparation by plaque
assay on BHK cells (Klimstra et al., 1998).
Polyacrylamide gel analysis of [35S]-methionine-labeled
viral proteins
Individual structural proteins from [35S]-methionine-la-
beled virus particles were resolved by SDS-PAGE (10%
acrylamide) under reducing conditions (50 mM 2-mercap-
toethanol) (Klimstra et al., 1999a). The radiolabeled protein
bands were visualized with a Storm model PhosphorImager
and ImageQuant software (Molecular Dynamics). The rel-
ative PE2 cleavage efficiency was determined by dividing
the image densities of bands corresponding to PE2 by the
total image density of PE2, E1, E2, and C proteins. The
results slightly underestimate the difference between cleav-
ing and noncleaving viruses due to the loss of E3, which
contains one methionine (a total of 27 in PE2), from the
PE2-cleaving virus lanes.Acknowledgments
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